Brainomix’s E-Lung Receives FDA Approval for ILD Diagnosis
Brainomix’s E-Lung Receives FDA Approval: A Game Changer in ILD Diagnosis Brainomix, a leading company specializing in advanced respiratory diagnostics, has recently announced that its groundbreaking E-Lung solution has received FDA approval. This innovative technology is set to revolutionize the diagnosis of Interstitial Lung Diseases (ILDs), a group of progressive lung conditions that can significantly…